The majority of last year’s 110 drug GMP warning letters, 56, went to compounding pharmacies, including 21 to registered outsourcing facilities.
That’s more than twice the number of warning letters FDA sent pharmacies in fiscal year 2015, but just 51% of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?